Patents by Inventor Colleen C. Garrett

Colleen C. Garrett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190202812
    Abstract: The present invention features crystalline polymorphs of dimethyl (2S,2?S)-1,1,-((2S,2?S)-2,2,-(4,4,-((2S,5S)-1-(4-tert-butylphenyl) pyrrolidine-2,5-diyl) bis (4,1-phenylene)) bis (azanediyl) bis (oxomethylene) bis (pyrrolidine-2,1-diyl)) bis (3-methyl-1-oxobutane-2,1-diyl) dicarbamate i.e. ombitasvir, compound (I), which is a potent HCV NS5A inhibitor. In one embodiment, a crystalline form of Compound (I) has characteristic peaks in the PXRD pattern as shown in one of FIGS. 1-11.
    Type: Application
    Filed: April 25, 2017
    Publication date: July 4, 2019
    Applicant: AbbVie Inc.
    Inventors: Paul J. Brackemeyer, Colleen C. Garrett, Fredrik Lars Nordstrom, Ahmad Y. Sheikh, Geoff G. Zhang, Donghua Zhu
  • Publication number: 20150322108
    Abstract: The present invention features crystalline forms of Compound I.
    Type: Application
    Filed: May 9, 2014
    Publication date: November 12, 2015
    Inventors: Colleen C. Garrett, Lars Fredrik Nordstroem, Donghua Zhu